These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
263 related items for PubMed ID: 2850196
1. Comparison of three paf-acether receptor antagonist ginkgolides. Korth R, Nunez D, Bidault J, Benveniste J. Eur J Pharmacol; 1988 Jul 26; 152(1-2):101-10. PubMed ID: 2850196 [Abstract] [Full Text] [Related]
2. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988. Nunez D, Chignard M, Korth R, Le Couedic JP, Norel X, Spinnewyn B, Braquet P, Benveniste J. Eur J Pharmacol; 1986 Apr 16; 123(2):197-205. PubMed ID: 3086108 [Abstract] [Full Text] [Related]
3. BN 52021 displaces [3H]paf-acether from, and inhibits its binding to intact human platelets. Korth R, Benveniste J. Eur J Pharmacol; 1987 Oct 27; 142(3):331-41. PubMed ID: 3428349 [Abstract] [Full Text] [Related]
4. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds. Baroggi N, Etienne A, Braquet P. Agents Actions Suppl; 1986 Oct 27; 20():87-97. PubMed ID: 3028108 [Abstract] [Full Text] [Related]
5. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba. Lamant V, Mauco G, Braquet P, Chap H, Douste-Blazy L. Biochem Pharmacol; 1987 Sep 01; 36(17):2749-52. PubMed ID: 2820421 [Abstract] [Full Text] [Related]
6. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021. Lachachi H, Plantavid M, Simon MF, Chap H, Braquet P, Douste-Blazy L. Biochem Biophys Res Commun; 1985 Oct 30; 132(2):460-6. PubMed ID: 2998370 [Abstract] [Full Text] [Related]
7. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets. Robaut C, Durand G, James C, Lave D, Sedivy P, Floch A, Mondot S, Pacot D, Cavero I, Le Fur G. Biochem Pharmacol; 1987 Oct 01; 36(19):3221-9. PubMed ID: 2822048 [Abstract] [Full Text] [Related]
9. CIS-19, a novel platelet activating factor receptor antagonist: in vitro and in vivo studies. Ko FN, Yu SM, Chen IS, Ishii H, Chang YL, Huang TF, Teng CM. Biochim Biophys Acta; 1993 Jan 17; 1175(2):225-31. PubMed ID: 8380343 [Abstract] [Full Text] [Related]
10. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists. Domingo MT, Piro F, Broquet C, Auclair E, Chabrier PE, Braquet P. Lipids; 1992 Aug 17; 27(8):582-6. PubMed ID: 1328798 [Abstract] [Full Text] [Related]
15. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. Stewart AG, Dusting GJ. Br J Pharmacol; 1988 Aug 17; 94(4):1225-33. PubMed ID: 2850058 [Abstract] [Full Text] [Related]
16. Effects of platelet-activating factor on electrophysiology of isolated retinas and their inhibition by BN 52021, a specific PAF-acether receptor antagonist. Doly M, Bonhomme B, Braquet P, Chabrier PE, Meyniel G. Immunopharmacology; 1987 Jun 17; 13(3):189-94. PubMed ID: 3038784 [Abstract] [Full Text] [Related]
17. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021. Kurihara K, Wardlaw AJ, Moqbel R, Kay AB. J Allergy Clin Immunol; 1989 Jan 17; 83(1):83-90. PubMed ID: 2536413 [Abstract] [Full Text] [Related]
18. Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists. Vogensen SB, Strømgaard K, Shindou H, Jaracz S, Suehiro M, Ishii S, Shimizu T, Nakanishi K. J Med Chem; 2003 Feb 13; 46(4):601-8. PubMed ID: 12570381 [Abstract] [Full Text] [Related]